108. Vibe Bio launches to transform drug development, Alok Tayi Ph.D. and Susanna Harris Ph.D.
Our guest this week is one of our hosts, Alok Tayi, and he has some exciting news. The official launch of his new company, Vibe Biotechnology, building a global community of patients, scientists, and...
22 Kesä 202219min
107. Fighting infectious diseases with biologics, Paul Garofolo, Co-founder & CEO, Locus Biosciences
Paul is the CEO & Co-founder of Locus Biosciences. With a career that spans manufacturing, research & development, information technology and corporate transformations, Paul brings a broad range of ex...
15 Kesä 202230min
106. Next-Gen CRISPR applications, Trevor Martin, Co-founder & CEO, Mammoth Biosciences
Dr. Trevor Martin founded Mammoth Biosciences with the mission to enable the next generation of CRISPR-based synthetic biology products across therapeutics and diagnostics, including a novel class of ...
8 Kesä 202225min
105. Gene therapy in hearing loss, Laurence Reid, PhD, CEO, Decibel Therapeutics
Laurence joined Decibel in January 2020. He previously served as an entrepreneur in residence at Third Rock Ventures, where he focused on novel drug discovery and development opportunities. Before tha...
1 Kesä 202237min
104. Embracing nerve repair, Karen Zaderej, CEO, Chairman, and President, Axogen
Ms. Zaderej has served as Axogen’s President, Chief Executive Officer, and a member of our Board of Directors since September 2011 and the Chairman of our Board of Directors since May 2018. Since May ...
25 Touko 202226min
103. Patient-driven thrombosis innovations, John Glasspool, CEO, Anthos Therapeutics
John Glasspool is CEO and member of the Board of Directors of Anthos Therapeutics. Mr. Glasspool is also a member of the Board of Directors of Dalcor Corporation. He was formerly the Executive Vice P...
18 Touko 202224min
102. Vanquishing Parkinson's Disease, Jim Sullivan, PhD, Co-founder & CEO, Vanqua Bio
Dr. Sullivan is co-founder and CEO of Vanqua. In addition, he has been a Venture Partner with Orbimed since January 2019. Previously, he was the Vice President of Research at Abbvie where he was respo...
11 Touko 202222min
101. Revolutionizing genetic medicine, Paula Soteropoulos, Chairman of the Board, Ensoma
Paula Soteropoulos brings to Ensoma more than 30 years of experience in the biopharma industry in areas of drug development, manufacturing, business development, global commercialization with P&L acco...
4 Touko 202229min
